Twist Bioscience Corp
TWST- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001581280
In the last 90 days, Twist Bioscience Corp insiders filed 0 open-market purchases and 30 sales; 337 institutions reported holding it in 13F filings for Q2 2026, worth $7.85B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Twist Bioscience Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +3 vs. Q2 2023
- Shares held
- 65.9M
- −1.93M (−2.8%) vs. Q2 2023
- Total value
- $1.34B
- −$43.5M (−3.1%) vs. Q2 2023
- New holders
- 28
- 58 more added
- Sold out
- 25
- 65 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TWST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $7.85B |
| Q1 2026 | 281 | $3.66B |
| Q4 2025 | 244 | $2.38B |
| Q3 2025 | 239 | $2.08B |
| Q2 2025 | 244 | $2.62B |
| Q1 2025 | 263 | $2.73B |
| Q4 2024 | 247 | $3.08B |
| Q3 2024 | 246 | $2.99B |
| Q2 2024 | 263 | $3.25B |
| Q1 2024 | 238 | $2.30B |
| Q4 2023 | 219 | $2.46B |
| Q3 2023 | 196 | $1.34B |
| Q2 2023 | 194 | $1.39B |
| Q1 2023 | 203 | $956.8M |
| Q4 2022 | 199 | $1.45B |
| Q3 2022 | 221 | $2.04B |
| Q2 2022 | 205 | $2.01B |
| Q1 2022 | 213 | $2.92B |
| Q4 2021 | 237 | $3.96B |
| Q3 2021 | 238 | $5.20B |
| Q2 2021 | 245 | $6.40B |
| Q1 2021 | 240 | $5.82B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Twist Bioscience Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −87,413−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −71,026−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −59,875−100.0% | Sold out |
| Koss-Olinger Consulting, LLC | 0 | $0 | 0.00% | −41,300−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −32,287−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −31,600−100.0% | Sold out |
| Connective Portfolio Management, LLC | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −28,152−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −26,587−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −24,482−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,653−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −13,582−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −12,439−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −11,076−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −10,727−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −10,205−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −10,144−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −612−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −521−100.0% | Sold out |
| Clearview Wealth Advisors LLC | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Kames Capital plc | – | – | – | – | Not filed |